A UNIQUE THERAPY 4 YOUR PATIENTS
STELARA® has a unique mechanism of action as the only available biologic that selectively targets IL-23 and IL-12 cytokines
ONLY 4 MAINTENANCE DOSES PER YEAR after 2 starter doses1*
*Every 12 weeks after 2 starter doses at Weeks 0 and 4.
Reference: 1. STELARA [package insert]. Horsham, PA: Janssen Biotech, Inc; 2016.